FDA Inspection 989086 — RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank
The FDA completed an inspection of RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank on September 22, 2016 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, NJ (United States)